Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

8.27
Delayed Data
As of Aug 28
 +0.79 / +10.56%
Today’s Change
6.23
Today|||52-Week Range
25.60
-48.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash74.7M40.6M17.8M37.3M
 
 
 
 
 
Short Term Investment Cash-12.1M31.4M-22.7M19.5M
 
 
 
 
 
Cash & Short Term Investments103.6M98.1M114.0M159.7M
 
 
 
 
 
 
ReceivablesReceivables0.000.0079.0K274.0K
 
 
 
 
InventoriesInventories0.000.00------
 
Current AssetsOther Current Assets522.0K829.0K3.1M4.9M
 
 
 
 
 
Current Assets104.2M98.9M117.2M165.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross4.6M5.8M7.5M8.7M
 
 
 
 
 
Depreciation-1.5M-2.4M-3.7M-5.2M
 
 
 
 
 
Intangible Assets980.0K1.2M1.1M1.2M
 
 
 
 
 
Other Assets1.1M1.3M2.1M3.0M
 
 
 
 
 
Total Assets108.4M103.5M123.1M171.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable501.0K311.0K1.2M2.2M
 
 
 
 
 
Short Term Debt0.000.000.0023.4M
 
 
Accrued Expenses359.0K658.0K3.0M4.4M
 
 
 
 
 
Other Current Liabilities11.1M11.1M7.9M7.5M
 
 
 
 
 
Other Liabilities12.5M12.8M10.4M35.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt5.6M10.1M11.3M0.00
 
 
 
 
Other Liabilities963.0K767.0K1.5M322.0K
 
 
 
 
 
Total Liabilities36.5M41.4M29.6M39.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity71.9M62.1M93.5M132.0M
 
 
 
 
 
Total Shareholder Equity71.9M62.1M93.5M132.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding34.1M35.8M41.8M48.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.